Keyphrases
Pharmacological Inhibitors
100%
Renin-angiotensin-aldosterone System
100%
Pathophysiological Roles
100%
Angiotensin Receptor Blockers
33%
Angiotensin I
33%
Cardiovascular Disease
22%
Renal Disease
22%
ACE Inhibitors
22%
Angiotensin II (Ang II)
22%
Disease Conditions
11%
Hypertension
11%
Hypertension Management
11%
Therapeutic Benefits
11%
Tissue Perfusion
11%
Therapeutic Strategies
11%
Beta-blockers
11%
Dysregulation
11%
Clinical Benefit
11%
Biological Activity
11%
Renin
11%
Arterial Pressure
11%
Regulated Secretion
11%
Hydrolysis
11%
Vasodilator
11%
Active Substances
11%
Therapeutic Approaches
11%
Related Conditions
11%
Combination Therapeutics
11%
Angiotensin-converting Enzyme Inhibitor (ACEi)
11%
Extracellular Volume
11%
New Therapeutic Modalities
11%
N-terminus
11%
Rate-limiting Enzyme
11%
Pharmacologic Agents
11%
Angiotensin-converting Enzyme
11%
Hypertensive Cardiovascular Disease
11%
Angiotensinogen
11%
Dual Blockade
11%
Homeostatic Control
11%
Aliskiren
11%
Perfusion Volume
11%
Direct Renin Inhibition
11%
Pharmacology, Toxicology and Pharmaceutical Science
Renin
100%
Angiotensin
100%
Aldosterone
100%
Dipeptidyl Carboxypeptidase Inhibitor
30%
Angiotensin I
30%
Angiotensin Receptor Antagonist
30%
Cardiovascular Disease
30%
Kidney Disease
20%
Angiotensin II
20%
Clinical Study
10%
Beta Adrenergic Receptor Blocking Agent
10%
Biological Activity
10%
Preclinical Study
10%
Dipeptidyl Carboxypeptidase
10%
Renin Inhibitor
10%
Angiotensinogen
10%
Aliskiren
10%